New research highlights nasal spray drug’s potential to counter Alzheimer’s by targeting brain enzyme dysfunction.
An experimental nasal spray has helped clear toxic protein buildups in the brains of mouse models of Alzheimer's. Its ...
The active agent in the nasal spray, 2-bromopalmitate, carries a high risk of interfering with a number of processes, making ...
Limitless Biotech, a leading innovator in the field of biohacking and cognitive enhancement, is proud to announce the launch ...
Italian researchers have developed a nasal spray showing promise in slowing Alzheimer's progression. Tests on mice with ...
A study conducted bà Cattolica in Rome and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS has uncovered a ...
A future treatment for Alzheimer disease may involve a nasal spray. Researchers at Università Cattolica and Fondazione ...
Bumetanide nasal spray (BNS) has statistical bioequivalence to oral bumetanide, according to a research letter publish ...
Neffy, a new epinephrine nasal spray, offers a less invasive option for treating allergic reactions. Learn about its benefits ...
A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe and well-tolerated (meaning with no significant nasal irritation) in ...
Researchers at Tel Aviv University have developed an effective, inexpensive, and simple COVID-19 vaccine that can be stored ...
The Federal Government is funding a national Take Home Naloxone (THN) program that makes the life-saving medication available ...